Surgical Treatment for Isolated Aortic Endocarditis: a Comparison with Isolated Mitral Endocarditis

대동맥 판막만을 침범한 감염성 심내막염의 수술적 치료: 승모판막만을 침범한 경우와 비교 연구

  • Hong, Seong-Beom (Department of Thoracic and Cardiovascular Surgery, Kwangju Veterans Hospital) ;
  • Park, Jeong-Min (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Lee, Kyo-Seon (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Ryu, Sang-Woo (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Yun, Ju-Sik (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • CheKar, Jay-Key (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Yun, Chi-Hyeong (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Kim, Sang-Hyung (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School) ;
  • Ahn, Byoung-Hee (Department of Thoracic and Cardiovascular Surgery, Chonnam National University Medical School)
  • 홍성범 (광주보훈병원 흉부외과) ;
  • 박정민 (전남대학교 의과대학 흉부외과학교실) ;
  • 이교선 (전남대학교 의과대학 흉부외과학교실) ;
  • 류상우 (전남대학교 의과대학 흉부외과학교실) ;
  • 윤주식 (전남대학교 의과대학 흉부외과학교실) ;
  • 제갈재기 (전남대학교 의과대학 흉부외과학교실) ;
  • 윤지형 (전남대학교 의과대학 흉부외과학교실) ;
  • 김상형 (전남대학교 의과대학 흉부외과학교실) ;
  • 안병희 (전남대학교 의과대학 흉부외과학교실)
  • Published : 2007.09.05

Abstract

Background: Infective endocarditis shows high surgical mortality and morbidity rates, especially for aortic endocarditis. This study attempts to investigate the clinical characteristics and operative results of isolated aortic endocarditis. Material and Method: From July 1990 to May 2005, 25 patients with isolated aortic endocarditis (Group I, male female=18 : 7, mean age $43.2{\pm}18.6$ years) and 23 patients with isolated mitral endocarditis (Group II, male female=10 : 13, mean age $43.2{\pm}17.1$ years) underwent surgical treatment in our hospital. All the patients had native endocarditis and 7 patients showed a bicuspid aortic valve in Group I. Two patients had prosthetic valve endocarditis and one patients developed mitral endocarditis after a mitral valvuloplasty in Group II. Positive blood cultures were obtained from 11 (44.0%) patients in Group I, and 10 (43.3%) patients in Group II, The pre-operative left ventricular ejection fraction for each group was $60.8{\pm}8.7%$ and $62.1{\pm}8.1%$ (p=0.945), respectively. There was moderate to severe aortic regurgitation in 18 patients and vegetations were detected in 17 patients in Group I. There was moderate to severe mitral regurgitation in 19 patients and vegetations were found in 18 patients in Group II. One patient had a ventricular septal defect and another patient underwent a Maze operation with microwaves due to atrial fibrillation. We performed echocardiography before discharge and each year during follow-up. The mean follow-up period was $37.2{\pm}23.5$ (range $9{\sim}123$) months. Result: Postoperative complications included three cases of low cardiac output in Group I and one case each of re-surgery because of bleeding and low cardiac output in Group II. One patient died from an intra-cranial hemorrhage on the first day after surgery in Group I, but there were no early deaths in Group II. The 1, 3-, and 5-year valve related event free rates were 92.0%, 88.0%, and 88.0% for Group I patients, and 91.3%, 76.0%, and 76.0% for Group II patients, respectively. The 1, 3-, and 5-year survival rates were 96.0%, 96.0%, and 96.0% for Group I patients, and foo%, 84.9%, and 84.9% for Group II patients, respectively. Conclusion: Acceptable surgical results and mid-term clinical results for aortic endocarditis were seen.

배경: 감염성 심내막염으로 인한 심장 수술은 위험률이 높은 것으로 알려져 있으며, 특히 대동맥 판막 심내막염 수술은 합병증 발생과 사망률이 높은 것으로 보고된다. 본 연구는 대동맥 판막만을 침범한 감염성 심내막염에 대한 임상 양상 및 수술 결과를 분석하고자 시행되었다. 대상 및 방법: 1990년 7월부터 2005년 5월까지 본원에서 대동맥 판막만을 침범한 감염성 심내막염으로 수술받은 환자를 1군(25예, 남자 : 여자=18 : 7, 평균 나이 $43.2{\pm}18.6$세), 승모판막만을 침범하여 수술 받은 환자를 2군(23예, 남자 : 여자=10 : 13, 평균 나이 $43.2{\pm}17.1$세)으로 하여 양군의 임상 양상 및 수술 결과를 비교 분석하였다. 술전 좌심실 구출률은 1군 $60.8{\pm}8.7%$, 2군 $62.1{\pm}8.1%$ (p=0.945)였다. 술 전 1군은 18예에서 중등도 이상의 대동맥 판막 역류증을 보였고, 17예에서 우종이 관찰되었으며, 동반 질환으로 심실 중격 결손증 2예와 동맥관 개존증 1예가 있었다. 2군은 19예에서 중등도 이상의 승모판막 역류증을 보였고, 18예에서 우종이 관찰되었으며, 동반 질환으로 심실 중격 결손증이 1예 있었으며, 1예에서 심방 세동으로 Microwave를 이용한 Maze 수술을 동시에 시행 받았다. 1군은 모두 자가 판막 심내막염이었으며, 7예에서 이엽성 대동맥 판막 소견을 보였으며, 2군은 인공판막 심내막염 2예, 승모판막 성형술 후 발생한 심내막염이 1예였다. 혈액 배양 검사상 1군은 11예(44.0%)에서 원인균이 동정되었으며, 2군은 10예(43.3%)에서 원인균이 동정되었다. 수술 직후에 심장 초음파를 시행하였으며, 이후 1년 간격으로 심장 초음파를 추적 검사하였다. 평균 추적 관찰 기간은 $37.2{\pm}23.5$ ($9{\sim}123$)개월 이었다. 결과: 수술 후 합병증으로 1군의 3예에서 저심박출증이 있었으며, 2군에서 출혈로 인한 재수술 1예, 저심박출증 1예가 있었다. 1군에서 수술 1일 후 뇌출혈로 인해 신경외과 수술을 받았으나 사망한 1예가 있었으며, 2군에서는 수술 사망률은 없었다. 1, 3, 5년 판막 관련 합병증이 발생하지 않을 확률은 1군은 각각 92.0%, 88.0%, 88.0%였으며, 2군은 91.3%, 76.0%, 76.0%였다. 수술 후 1, 3, 5년 생존율은 1군에서 각각 96.0%, 96.0%, 96.0%였으며, 2군은 각각 100%, 84.9%, 84.9%였다. 결론: 대동맥 판막만을 침범한 감염성 심내막염 환자의 수술적 치료는 만족할 만한 임상 결과와 중, 단기 결과를 보여 주었다.

Keywords

References

  1. Wallace AG, Young WG, Osterhout S. Treatment of acute bacterial endocarditis by valve excision and replacement. Circulation 1965;31:450-3 https://doi.org/10.1161/01.CIR.31.3.450
  2. Anguera I, Miro JM, Cabell CH, et al. Clinical characteristics and outcome of aortic endocarditis with periannular abscess in the internationalcollaborationon endocarditis merged database. Am J Cardiol 2005;96:976-81 https://doi.org/10.1016/j.amjcard.2005.05.056
  3. Jassal DS, Neilan TG, Pradhan AD, et al. Surgical management of infective endocarditis: early predictors of short-term morbidity and mortality. Ann Thorac Surg 2006;82:524-9 https://doi.org/10.1016/j.athoracsur.2006.02.023
  4. Alexiou C, Langley SM, Stafford H, et al. Surgical treatment of infective mitral valve endocarditis: predictors of early and late outcome. J Heart Valve Dis 2000;9:327-34
  5. Aranki SF, Santini F, Adams DH, et al. Aortic valve endocarditis. Determinants of early survival and late morbidity. Circulation 1994;90(5 Pt 2):II175-82
  6. Reyes MP, Lerner AM. Current problems in the treatment of endocarditis due to pesudomonas aeruginosa. Rev Infect Dis 1983;5:314-21 https://doi.org/10.1093/clinids/5.2.314
  7. Bayer AS. Staphylococcal bacteremia and endocarditis: state of the art. Arch Intern Med 1985;142:1169-77 https://doi.org/10.1001/archinte.142.6.1169
  8. Bonow RO, Carbello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. A report from the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Call Cardiol 1998;32: 1486-588 https://doi.org/10.1016/S0735-1097(98)00454-9
  9. Edmunds LH, Clark RE, Cohn LH, et al. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ann Thorac Surg 1996;62:932-5 https://doi.org/10.1016/S0003-4975(96)00531-0
  10. Choi SH, Yang HW, Lee SY, Result of surgical treatment for infective endocarditis. Korean J Thorac Cardiovasc Surg 1996;29:157-63
  11. Bashore TM, Cabell C, Fowler V. Update on infective endocarditis. Curr Probl Cardiol 2006;31:274-352 https://doi.org/10.1016/j.cpcardiol.2005.12.001
  12. d'Udekem Y, David TE, Feindel CM, Armstrong S, Sun Z. Long-term results of surgery for active infective endicarditis. Eur J Cardiothorac Surg 1997;11:46-52 https://doi.org/10.1016/S1010-7940(96)01020-2
  13. Dinubile MJ. Surgery in active endocarditis. Ann Intern Med 1982;96:650-9 https://doi.org/10.7326/0003-4819-96-5-650
  14. Uwaydah MM, Weinberg AN. Bacterial endocarditis: a changing pattern. N Engl J Med 1965;273:1231-5 https://doi.org/10.1056/NEJM196512022732301
  15. Baumgartner WA, Miller DC, Reitz BA, et al. Surgical treatment of prosthetic valve endocarditis. Ann Thorac Surg 1983;35:87-104 https://doi.org/10.1016/S0003-4975(10)61436-1
  16. Cowgill LD, Addonizio VP, Hopeman AR, Harken AH. A practical approach to prosthetic valve endocarditis. Ann Thorae Surg 1987;43:450-7 https://doi.org/10.1016/S0003-4975(10)62835-4
  17. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the committee on rheumatic fever, endocarditis, and kawasaki disease, council on cardiovascular disease in the young, and the councils on clinical cardiology, stroke, and cardiovascular surgery and aesthesia, American Heart Association: endorsed by the Infectious dseases sciety of America. Circulation 2005;111:e394-434 https://doi.org/10.1161/01.CIR.0000153812.64956.EF